Mow Jonathan P

USNatural personCEO

Insider

Mow Jonathan P

USNatural personCEO

Transactions

Issuers

Buys / Sells

3/0

Last tx

20 May 2022

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
PhaseBio Pharmaceuticals Inc	132,502	reported	20 May 2022	tx 33+1,616,317−112,169

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
20 May 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	10,918	0.68 USD
24 Feb 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	82,500	0.00 USD	deriv
24 Feb 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	385,000	0.00 USD	deriv
19 Nov 2021	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	5,623	2.01 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
PhaseBio Pharmaceuticals Inc	132,502	reported	20 May 2022	tx 33+1,616,317−112,169

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
20 May 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	10,918	0.68 USD
24 Feb 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	82,500	0.00 USD	deriv
24 Feb 2022	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	385,000	0.00 USD	deriv
19 Nov 2021	GRANT_AWARD	PhaseBio Pharmaceuticals Inc	5,623	2.01 USD